Net costs due to seasonal influenza vaccination-United States, 2005-2009

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Carias, Cristina ^a,b   Reed, Carrie ^a   Kim, Inkyu K ^a,c   Foppa, Ivo M ^a,c   Biggerstaff, Matthew ^a   Meltzer, Martin I ^a   Finelli, Lyn ^a   Swerdlow, David L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ihrc Inc   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEVER; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HEADACHE; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; INFANT; INFLUENZA VACCINATION; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALAISE; MORBIDITY; MORTALITY; MYALGIA; SEASONAL INFLUENZA; SEASONAL VARIATION; TREATMENT OUTCOME; UNITED STATES; ADOLESCENT; COHORT ANALYSIS; ECONOMIC MODEL; ECONOMICS; FEMALE; HEALTH CARE COST; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; SEASON; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, ECONOMIC; SEASONS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84941985340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132922     Document Type: Article

References (32)

1. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1-62.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086-5096. PMID: 17544181
3. Thompson MG, Shay DK, Zhou H, Bridges CB, PY Cheng PY, Burns E, et al. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59:1057-1062. PMID: 20798667
4. Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12:1548-1558. PMID: 17176570
5. Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Messonnier ML, et al. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics. 2008;26:163-178. PMID: 18198935
6. Newall AT, Kelly H, Harsley S, Scuffham PA. Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group. Pharmacoeconomics. 2009;27:439-450. PMID: 19640008
7. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784. PMID: 8065407
8. Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence. Drugs. 2002;62:1013-1024. PMID: 11985488
9. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis. 2009;15:2004-2007. doi: 10.3201/eid1512.091413 PMID: 19961687
10. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011;52 Suppl 1:S75-82. doi: 10.1093/cid/ciq012 PMID: 21342903
11. Kostova D, Reed C, Finelli L, Cheng PY, Gargiullo PM, Shay DK, et al. Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One. 2013;8:e66312. PMID: 23840439
12. Foppa IM, Cheng PY, Reynolds SB, Shay DK, Carias C, Bresee JS, et al. Deaths averted by influenza vaccination in the U. S. during the seasons 2005/06 through 2013/14. Vaccine. 2015; In press.
13. People at High Risk of Developing Flu-Related Complications, Centers for Disease Control and Prevention. Available: http://www.cdc.gov/flu/about/disease/high-risk.htm. Accessed April 1 2015.
14. Keren R, Zaoutis TE, Saddlemire S, Luan XQ, Coffin SE. Direct medical cost of influenza-related hospitalizations in children. Pediatrics. 2006;118:e1321-1327. PMID: 17079533
15. Centers for Disease Control and Prevention. Flu Vaccination Coverage by High-Risk Conditions, Adults, BRFSS. Available: http://www.cdc.gov/flu/fluvaxview/brfss-high-risk.htm. Accessed April 1 2015.
16. Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, et al. Influenza- and RSVassociated hospitalizations among adults. Vaccine. 2007;25:846-855. PMID: 17074423
17. Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine. 2010;28:6470-6477. doi: 10.1016/j.vaccine. 2010.07.037 PMID: 20674882
18. (2012) Statistical Abstract of the U. S.-Table 725. United States Census Bureau. Available: http://www.census.gov/compendia/statab/2012edition. html. Accessed April 1 2015.
19. Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, et al. High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine. 2010;28:4913-4919. doi: 10.1016/j.vaccine.2010.05.036 PMID: 20576536
20. Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006;118:2409-2417. PMID: 17142526
21. Hall JL, Katz BZ. Cost of influenza hospitalization at a tertiary care children's hospital and its impact on the cost-benefit analysis of the recommendation for universal influenza immunization in children age 6 to 23 months. J Pediatr 2005;147:807-811. PMID: 16356436
22. Haddix AC, Teutsch SM, Corso PS. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed. New York: Oxford University Press; 2003.
23. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis. 1999;5:659-671. PMID: 10511522
24. United States Department of Labor, Bureau of Labor Statistics. Occupational Labor Statistiscs-May 2009 National Occupational Employment and Wage Estimates United States. Available: http://www.bls.gov/oes/2009/may/oes-nat.htm# 00-0000. Accessed April 1 2015.
25. United States Department of Labor, Bureau of Labor Statistics. American Time Use Survey-2013 Results (Table 4). Available: http://www.bls.gov/news.release/pdf/atus.pdf. Accessed April 1 2015.
26. United States Department of Labor, Bureau of Labor Statistics. Labor Force Statistics from the Current Population Survey-2014. Available: http://www.bls.gov/cps/cpsaat03.htm. Accessed April 1 2015.
27. Coleman MS, Fontanesi J, Meltzer MI, Shefer A, Fishbein DB, Bennett NM, et al. Estimating medical practice expenses from administering adult influenza vaccinations. Vaccine. 2005;23:915-923. PMID: 15603893
28. Kennedy ED, Santibanez TA, Bryan LN, Wortley PM, Euler GL, Singleton JA, et al. Place of influenza vaccination among adults-United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep. 2011;60:781-785. PMID: 21681175
29. Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10:643-651. doi: 10.1016/S1473-3099 (10) 70140-7 PMID: 20797646
30. Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, et al. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med. 1996;156:1546-1550. PMID: 8687262
31. Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, et al. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31:6030-6033. doi: 10. 1016/j.vaccine.2013.09.063 PMID: 24095882
32. McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. Vaccine. 2014;32:453-457. doi: 10.1016/j.vaccine.2013. 11.060 PMID: 24291201